COVID-19: How RBC Wealth Management is helping clients. Learn more
COVID-19 has left economies and companies operating in a state of business as unusual. So, when it comes to the outlook for corporate profits, it’s time to throw out the playbook.
While stock markets remain on a road littered with potholes, a confluence of catalysts has facilitated a forceful rebound. We size up the bounce in global equities.
Economies and companies are operating in a state of business as unusual. When it comes to the earnings outlook, it’s time to throw out the playbook.
Equity markets have made up much of their lost ground since their March lows as COVID-19 infection and mortality rates have improved in North America and Europe, and as rays of light have started shining into the quarantine tunnel.
COVID-19 has brought companies and countries together for a common goal. We examine that search for treatments and vaccines.
While stock markets remain on a road littered with potholes, a confluence of catalysts has facilitated a forceful rebound.
With the unrelenting speed and sway of newsflow over the past few weeks, market moves that would have normally attracted attention have largely passed with nary a glance.
Chinese equities are a case in point. Their recent outperformance has been more abrupt than most think.
The paths of financial markets and economies almost always involve uncertainties—it’s par for the course. But the abundance of uncertainties brought about by COVID-19 is making the science (and art) of economic forecasting unusually difficult.
The Fed is adding a new twist to its asset purchase program by buying corporate and municipal bonds. The question is, should investors do the same?
Download The Global Insight Monthly for an in-depth review on:
Download the Global Insight 2021 Midyear Outlook for an in-depth review on: